Patents by Inventor Youn Sook Lee

Youn Sook Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230018246
    Abstract: Pyrrolidine carboxamido derivatives, optical isomers thereof, and salts thereof that are able to prevent, improve, and/or treat inflammatory conditions, including inflammatory bowel disease, and methods for preparing and using the same are provided.
    Type: Application
    Filed: August 3, 2022
    Publication date: January 19, 2023
    Applicants: Research & Business Foundation Sungkyunkwan University, Korea Research Institute of Chemical Technology
    Inventors: Kwangho LEE, Sang Dal Rhee, Gildon Choi, Imran Ali, Chong Hak Chae, Moon Kook Jeon, Seok Hee Park, Youn Sook Lee
  • Patent number: 11365215
    Abstract: Pyrrolidine carboxamido derivatives, optical isomers thereof, and salts thereof that are able to prevent, improve, and/or treat inflammatory conditions, including inflammatory bowel disease, and methods for preparing and using the same are provided.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: June 21, 2022
    Assignees: Korea Research Institute of Chemical Technology, Research & Business Foundation Sungkyunkwan University
    Inventors: Kwangho Lee, Sang Dal Rhee, Gildon Choi, Imran Ali, Chong Hak Chae, Moon Kook Jeon, Seok Hee Park, Youn Sook Lee
  • Publication number: 20180208625
    Abstract: Pyrrolidine carboxamido derivatives, optical isomers thereof, and salts thereof that are able to prevent, improve, and/or treat inflammatory conditions, including inflammatory bowel disease, and methods for preparing and using the same are provided.
    Type: Application
    Filed: March 14, 2018
    Publication date: July 26, 2018
    Inventors: Kwangho Lee, Sang Dal Rhee, Gildon Choi, Imran Ali, Chong Hak Chae, Moon Kook Jeon, Seok Hee Park, Youn Sook Lee
  • Publication number: 20170198011
    Abstract: Disclosed is a pharmaceutical composition comprising a Smad6-derived peptide as an active ingredient. Having ability to specifically bind to Pellino-1, the Smad6-derived peptide is effectively useful in the treatment of the sepsis mediated by excessively activated TLR. The peptide effectively reduces the expression of inflammatory cytokines, protects cells from sepsis-induced apoptosis, and exhibits high bacterial clearance in animal models of sepsis.
    Type: Application
    Filed: November 5, 2015
    Publication date: July 13, 2017
    Applicant: Medpacto, Inc.
    Inventors: Seok Hee PARK, Youn Sook LEE, Yoe-Sik BAE, Seong-Jin KIM
  • Publication number: 20170008924
    Abstract: Pyrrolidine carboxamido derivatives, optical isomers thereof, and salts thereof that are able to prevent, improve, and/or treat inflammatory conditions, including inflammatory bowel disease, and methods for preparing and using the same are provided.
    Type: Application
    Filed: July 8, 2016
    Publication date: January 12, 2017
    Inventors: Kwangho Lee, Sang Dal Rhee, Gildon Choi, Imran Ali, Chong Hak Chae, Moon Kook Jeon, Seok Hee Park, Youn Sook Lee
  • Patent number: 9227997
    Abstract: Disclosed is a pharmaceutical composition comprising a Smad6-derived peptide as an active ingredient. Having ability to specifically bind to Pellino-1, the Smad6-derived peptide is effectively useful in the treatment of the sepsis mediated by excessively activated TLR. The peptide effectively reduces the expression of inflammatory cytokines, protects cells from sepsis-induced apoptosis, and exhibits high bacterial clearance in animal models of sepsis.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: January 5, 2016
    Assignee: Medpacto, Inc.
    Inventors: Seok Hee Park, Youn Sook Lee, Yoe Sik Bae, Seong-Jin Kim